54°F
weather icon Cloudy
Las Vegas, NV
Health

Moderna gets $176M to develop vaccine to treat bird flu

The U.S. government will pay the vaccine maker Moderna $176 million to develop a pandemic vaccine that could be used to treat bird flu in people as cases in dairy cows continue to mount across the country. (Las Vegas Review-Journal)
A patient is given a flu vaccine Oct. 28, 2022, in Lynwood, Calif. On Tuesday, July 2, 2024, th ...
A patient is given a flu vaccine Oct. 28, 2022, in Lynwood, Calif. On Tuesday, July 2, 2024, the U.S. Department of Health and Human Services announced plans to pay Moderna $176 million to develop a mRNA vaccine to treat bird flu in people, as cases in dairy cows continue to mount across the country. (AP Photo/Mark J. Terrill, File)
More Stories
Most colds are caused by rhinoviruses, which can lead to sneezing, sniffling, cough, stuffy, ru ...
Tips for treating your child during cold and flu season
A new study shows ultraprocessed foods may be fueling cancerous colon growths. (Getty Images)
How junk food may be feeding cancerous tumors
Greek yogurt has 10.3 grams of protein per 100-gram portion, compared with 11 grams in a simila ...
Cottage cheese vs. Greek yogurt: Which one’s healthier?
People often can be too ambitious in setting their new year fitness goals. As a result, they us ...
3 easy steps to follow through on New Year’s fitness goals
By The Associated Press
July 2, 2024 - 7:47 am
 

The U.S. government will pay the vaccine maker Moderna $176 million to develop a pandemic vaccine that could be used to treat bird flu in people as cases in dairy cows continue to mount across the country, federal officials announced Tuesday.

The funds are targeted for release through the U.S. Department of Health and Human Services and will pay for continued development of a vaccine that uses the same mRNA technology that allowed rapid development and rollout of vaccines to protect against COVID-19. The award was made through the Biomedical Advanced Research and Development Authority, or BARDA, a program that focuses on medical treatments for potential pandemics.

Moderna will launch trials to test the safety and effectiveness of a vaccine that could be used to scale up a response to a bird flu pandemic, if needed.

The H5N1 virus was detected earlier this year in dairy cows and has spread to more than 135 herds in 12 states and infected three people to date, all with mild cases. Federal health officials stress that the risk to the wider population remains low.

THE LATEST
A new study shows ultraprocessed foods may be fueling cancerous colon growths. (Getty Images)
How junk food may be feeding cancerous tumors
By Christopher O’Donnell Tampa Bay Times

Junk food like potato chips, ice cream and ready-made meals have long been linked with a spate of health conditions

Greek yogurt has 10.3 grams of protein per 100-gram portion, compared with 11 grams in a simila ...
Cottage cheese vs. Greek yogurt: Which one’s healthier?
By Beth Ann Mayer Parade

To help settle the score, we spoke with registered dietitians and grabbed nutrition information from the U.S. Department of Agriculture’s FoodData Central.

A polygenic risk score estimates the overall risk someone has of getting a disease by adding up ...
Could a personal health guide forecast your well-being?
Mayo Clinic News Network

Previously inconceivable, such personal guides to well-being are becoming increasingly possible because of new and sophisticated genome-wide technologies.

With Medicare, what you don't know will cost you. (Getty Images)
What is Medicare’s general enrollment period?
By Toni King Toni Says

Waiting too long to enroll can result in a penalty that remains in effect for the life of a beneficiary’s Medicare coverage.

Middleweight champion Claressa Shields celebrates after defeating reigning WBC women's heavywei ...
‘Be a champion of your own life,’ boxing star urges
By C.L. Gaber Special / RJ

“The Fire Inside” shares the inspirational story of how Claressa Shields conquered the odds with a pair of boxing gloves and a positive mindset.